Basu Sandip, Alavi Abass
Nucl Med Rev Cent East Eur. 2009;12(1):1-13.
In this communication, we present an overview of the impact and advantages of PET and PET-CT fusion imaging in the practice of medicine. We also discuss the evolution of this promising molecular imaging technique since its inception and the future prospects of the combined structure-function approach. Superior contrast resolution, accurate quantification and above all optimal image quality aid in improved diagnosis of many serious disorders including cancer. We speculate that this powerful imaging approach will almost completely replace most other conventional methods in the future. Currently, 18[F]-fluorode- -oxyglucose (FDG) is the main radiopharmaceutical employed for PET studies around the globe. With the availability of high quality PET images on a routine basis in most centres around the world and the likelihood that several other useful PET tracers will be approved in the near future for routine clinical applications, this technique will likely become essential in almost any medical disorder.
在本通讯中，我们概述了正电子发射断层扫描（PET）及PET-CT融合成像在医学实践中的影响和优势。我们还讨论了这一前景广阔的分子成像技术自诞生以来的发展历程以及结构-功能联合方法的未来前景。卓越的对比度分辨率、准确的定量分析，最重要的是优化的图像质量，有助于改善包括癌症在内的许多严重疾病的诊断。我们推测，这种强大的成像方法在未来几乎将完全取代大多数其他传统方法。目前，18[F]-氟脱氧葡萄糖（FDG）是全球PET研究中使用的主要放射性药物。随着世界上大多数中心能够常规获取高质量的PET图像，以及未来可能有几种其他有用的PET示踪剂被批准用于常规临床应用，这项技术在几乎任何医学疾病中都可能变得至关重要。
